Clinical trial · Interventional
Implementation of the ERAS in Colorectal Cancer Patients: a Single Arm Study
Implementation of the Early Recovery After Surgery (ERAS) Protocol in Colorectal Cancer Patients: a Phase II Multi-Center, Prospective Single Arm Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to implement and investigate the efficacy of an Early Recovery After Surgery (ERAS) protocol in South Korean colorectal cancer patients. The primary outcome will be the postoperative time taken to achieve the 'discharge criteria'. Secondary outcomes will include adherence, hospital stay, early complications, mortality, pain scores, re-admission and quality of life questionnaire scores. As a single arm study, all participants will be treated according to an ERAS protocol, which includes components such as early ambulation, minimal fasting, multimodal pain control and omission of- or early removal of invasive catheters.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ERAS protocol | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- ERAS implemented arm
- description
- ERAS protocol implemented patients (single arm).
- interventionNames
- Procedure: ERAS protocol
Primary outcomes (1)
- measure
- Postoperative time to discharge criteria
- timeFrame
- From the date of surgery until the date of first achieving all of the discharge criteria, assessed up to 100 days
- description
- The time (days) from initiation of surgery to achieving the discharge criteria. Discharge criteria is defined as meeting all of the following criteria: * No fever * Eating more than half of given solid diet * No nausea or vomiting * Gas passing or defecation * Able to walk (more than 1 hour a day) * No sign of surgical site infection * Adequate pain control with oral analgesics such as acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) * No sign of any other complication
Secondary outcomes (7)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * Above the age of 19 years * Pathologic diagnosis of colon cancer or rectal cancer * Scheduled for minimally invasive (laparoscopic or robotic) colorectal cancer surgery * Agreed to participate after a detailed explanation of the study Exclusion Criteria: * Stage 4 (distant metastasis) * Emergency surgery * Scheduled for transanal surgery * Perforated colorectal cancer * Obstructed colorectal cancer * Familial colorectal cancer (HNPCC, FAP, MUYH polyposis, Peutz-Jeghers syndrome) * Previous treatment for colorectal cancer * History of other cancer within 5 years (excluding skin cancer) * Acute infection * Unable to read or understand the study * Mental impairment
References
Publications (0)
Data not yet available